• OPEN AN ACCOUNT
Indian Indices
Sensex
74,529.08 -329.91
( -0.44%)
Global Indices
Nasdaq
52,073.35 369.71
(0.72%)
Dow Jones
7,785.28 113.78
(1.48%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,737.46 78.33
(0.73%)
Forex
USD-INR
95.99 0.12
(0.12%)
EUR-INR
110.24 0.24
(0.22%)
GBP-INR
128.54 0.36
(0.28%)
JPY-INR
0.61 0.00
(-0.53%)

EQUITY - MARKET SCREENER

IIFL Finance Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
532636
INE530B01024
177.1509312
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IIFL
17.45
25967.24
EPS(TTM)
Face Value()
Div & Yield %
34.86
2
0.66
 

Ishita Drugs & Industries standalone net profit declines 37.93% in the March 2026 quarter
Jun 01,2026
Net profit of Ishita Drugs & Industries declined 37.93% to Rs 0.18 crore in the quarter ended March 2026 as against Rs 0.29 crore during the previous quarter ended March 2025. Sales declined 32.89% to Rs 3.06 crore in the quarter ended March 2026 as against Rs 4.56 crore during the previous quarter ended March 2025.

For the full year,net profit declined 10.34% to Rs 0.78 crore in the year ended March 2026 as against Rs 0.87 crore during the previous year ended March 2025. Sales declined 2.27% to Rs 14.66 crore in the year ended March 2026 as against Rs 15.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3.064.56 -33 14.6615.00 -2
OPM %3.276.36 -5.256.67 -
PBDT0.300.41 -27 1.181.27 -7
PBT0.280.38 -26 1.081.16 -7
NP0.180.29 -38 0.780.87 -10